ReviewCardiovascular diagnosis and therapy2016
Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies.
Review in Cardiovascular diagnosis and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Reconciling Coronary Artery Calcification in the Lipid-Lowering Era.JACC. Advances · 2026Article
- Recent Trends in Artificial Intelligence-Assisted Coronary Atherosclerotic Plaque Characterization.International journal of environmental research and public health · 2021Review
- Does Lowering Low-Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle-Aged Adults? Analysis of the Observational MESA Study.Journal of the American Heart Association · 2021 · on this mapObservational
- Progression of coronary atherosclerosis in patients without standard modifiable risk factors.American journal of preventive cardiology · 2020Article
- The role of intracoronary imaging in translational research.Cardiovascular diagnosis and therapy · 2020Review
- Artificial Intelligence in Intracoronary Imaging.Current cardiology reports · 2020Review
- A post-market, multi-vessel evaluation of the imaging of peripheral arteries for diagnostic purposeS comparing optical Coherence tomogrApy and iNtravascular ultrasound imaging (SCAN).BMC medical imaging · 2020Article
- Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.Therapeutic advances in chronic disease · 2019Review
- Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?Digestive diseases and sciences · 2018Observational
- Pan-vascular disease: what we have done in the past and what we can do in the future?Cardiology plusArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite advances in risk prediction, preventive and therapeutic strategies, atherosclerotic cardiovascular disease remains a major public health challenge worldwide, carrying considerable morbidity, mortality and health economic burden. There continues to be a need to better understand the natural history of this disease to guide the development of more effective treatment, integral to which is the rapidly evolving field of coronary artery imaging. Various imaging modalities have been refined to enable detailed visualization of the pathological substrate of atherosclerosis, providing accurate and reproducible measures of coronary plaque burden and composition, including the presence of high-risk characteristics. The serial application of such techniques, including coronary computed tomography angiography (CTA), intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have uncovered important insights into the progression of coronary plaque over time in patients with stable and unstable coronary artery disease (CAD), and its responsiveness to therapeutic interventions. Here we review the use of different imaging modalities for the surveillance of coronary atherosclerosis and the lessons they have provided about the modulation of CAD by both traditional and experimental therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.